ACS ProSpectives conferences planned on crystalline polymorphism in February and catalysis in March

February 05, 2003

The American Chemical Society, the world's largest scientific society, will hold ACS ProSpectives conferences on crystalline polymorphism in February and catalysis in March. Polymorphism in Crystals: Fundamentals, Prediction and Industrial Practice will be held Feb. 23-26 at the Saddle Brook Resort, Tampa, Fla., and Catalysis in Modern Organic Synthesis will be held March 2-5 at the Cambridge Marriott in Cambridge, Mass.

ACS ProSpectives is a series of small conferences for senior-level industry scientists. Each conference examines a field's important topics through presentations by its foremost researchers.

Space is limited for both conferences. Polymorphism in crystals conference
The state-of-the-art in the often-misunderstood field of crystalline polymorphism will be presented by leading experts in polymorph characterization and prediction, with an emphasis on industrial applications and practice. Among the topics at this meeting are crystallization fundamentals and strategies, polymorph prediction and modeling, polymorph characterization and screening and patenting polymorphs.

The conference also will explore new discoveries that are changing views about polymorphism.

Chairs for the conference: Robin D. Rogers, The University of Alabama; Allan Myerson, Illinois Institute of Technology; Susan Reutzel-Edens, Eli Lilly; and Roger J. Davey, UMIST (United Kingdom).

Catalysis conference
The conference will explore catalytic methodologies for organic synthesis, with a special emphasis on technologies with applications in pharmaceutical science. It will include discussion about which new synthetic methodologies will have the greatest impact on drug discovery and production.

Among the subjects to be addressed are asymmetric catalysis, catalysis in total synthesis, organocatalysis and C-C and C-X formation.

Conference chairs are Stephen Buchwald and Gregory Fu, both of MIT; and Eric Jacobsen, Harvard University.

This year's ACS ProSpectives conferences will concentrate on several areas of rapidly changing interdisciplinary research. Attendance at the conferences is limited to 200 or fewer to facilitate easy interaction among the speakers and those attending. From 20-25 leading experts in each field participate in a given conference.

"ACS ProSpectives conferences are unique in that they are designed in format and content solely to meet the needs of scientists employed in industry," according to John Katz, ACS ProSpectives program director. "We offer leading edge information presented by the world's foremost researchers, but keep our conferences small to optimize informal interaction among participants."

The conferences are in addition to the Society's two national meetings and its eight to ten regional meetings held every year. Following are the topics, conference chairs, dates and locations for the remaining confirmed 2003 ACS ProSpectives Conferences that follow those in February and March:

ADMET in the 21st Century: A Comprehensive Review of Technology and Strategic Applications
Rod Cole, Millennium Pharmaceuticals; Tim Olah, Bristol Myers Squibb
Tampa, Fla.
May 4-6, 2003

Combinatorial Chemistry: New Methods, New Discoveries
Anthony Czarnik, editor, Journal of Combinatorial Chemistry; Michael Organ, York
University, Canada; A. Ganesan, University of Southampton, UK
Lansdowne Conference Center
Leesburg, Va.
September 21-24, 2003

Integrating Proteomics into System Biology
Ruth Van Bogelen, Pfizer; Eric Neumann, Beyond Genomics
Lansdowne Conference Center
Leesburg, Va.
Nov. 9-12, 2003

Further details about the conferences, including instructions on how to register and arrange lodging, are available on This site will be updated regularly with the latest information about upcoming ACS ProSpectives conferences.
(EDITOR's NOTE -- News media wishing to attend the conferences should contact Michael Bernstein at 202-872-6042 or at

American Chemical Society

Related Polymorphism Articles from Brightsurf:

Decreased MIR2911 absorption in human with SIDT1 polymorphism fails to inhibit SARS-CoV-2
In a new study in Cell Discovery, Liang Li and Chen-Yu Zhang's group at Nanjing University and two other groups report that SIDT1 polymorphism remarkably decreases HD-MIR2911 absorption in human.

MAX binding with the variant Rs72780850 in RNA helicase DDX1 for susceptibility to neuroblastoma
The researchers adopted the functional polymorphism research strategy to screen out the functional polymorphisms associated with neuroblastoma in Chinese population and elucidate its mechanism, providing data on children susceptible to neuroblastoma in China.

Amygdala changes in male patients with schizophrenia and bipolar disorder
Researchers in Japan have revealed that DNA methylation occurs in the serotonin transporter gene that regulates neurotransmitter transmission in schizophrenia and bipolar patients.

Organic heterostructures composed of one- and two-dimensional polymorph
A recent study facilely synthesized the OHSs composed of these two polymorph phases, whose growth mechanism is attributed to the low lattice mismatch rate of 5.8% between (001) plane of α phase (trunk) and (010) crystal plane of β phase (branch), Significantly, the multiport in/output channels can be achieved in the OHSs, which demonstrates the structure-dependent optical signals with the different output channels in the OHSs.

Scientists identify genetic variation linked to severity of ALS
A discovery made several years ago in a lab researching asthma at Wake Forest School of Medicine may now have implications for the treatment of amyotrophic lateral sclerosis (ALS), a disease with no known cure and only two FDA-approved drugs to treat its progression and severity.

Genetic flaw causes problems for many with hypothyroidism
Nearly 120 million prescriptions for a thyroid medicine called levothyroxine are filled each year, but many patients with hypothyroidism never get the benefit.

Biosensor chip detects single nucleotide polymorphism wirelessly, with higher sensitivity
A team led by the University of California San Diego has developed a chip that can detect a type of genetic mutation known as a single nucleotide polymorphism (SNP) and send the results in real time to an electronic device.

Thyroid gene variation may increase risk for Alzheimer's disease in African Americans
African Americans with a common genetic variation are at increased risk for developing Alzheimer's disease, while European Americans with the same variation are not, according to a study led by researchers at Rush University Medical Center.

New forms of orchids identified and described by Lobachevsky University scientists
At the 22nd World Orchid Conference held in Guayaquil, Ecuador, Lobachevsky University was represented by Director of the Botanical Garden Alexander Shirokov and head of the laboratory at the UNN Institute of Biology and Biomedicine Lavr Kryukov who shared the results of their studies of the polymorphism of Cypripedium guttatum flowers in Russia.

Chemists identify genetic mutation that opens door in combatting age-related diseases
Researchers at the University of Surrey, in collaboration with the Universities of Reading and Cologne, and the Royal Berkshire Hospital, have discovered that it is possible to stop the activation of a group of proteins (NADPH Oxidase) known to cause most of the diseases of ageing.

Read More: Polymorphism News and Polymorphism Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to